Christoph Sven Hoffmann
Director/Miembro de la Junta en EASTPHARMA LTD. .
Perfil
Christoph Sven Hoffmann currently works at Sallfort Privatbank AG, as Chairman-Supervisory Board, Eastpharma Ltd., as Independent Director, and Esocap AG, as Director.
Mr. Hoffmann also formerly worked at Molecular Health, Inc., as Director and Roche Hong Kong Ltd., as Regional Manager from 1983 to 1991.
Mr. Hoffmann received his graduate degree from the University of Basel.
Cargos activos de Christoph Sven Hoffmann
Empresas | Cargo | Inicio |
---|---|---|
EASTPHARMA LTD. | Director/Miembro de la Junta | - |
Sallfort Privatbank AG
Sallfort Privatbank AG Regional BanksFinance Sallfort Privatbank AG provides commercial banking, investment advisory, and asset management services. It also specializes in private equity, corporate finance, e-banking, and art consulting. The company was founded in 1981 and is headquartered in Zurich, Switzerland. | Presidente | - |
Esocap AG
Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Christoph Sven Hoffmann.
Empresas | Cargo | Fin |
---|---|---|
Roche Hong Kong Ltd. | Corporate Officer/Principal | 01/01/1991 |
Molecular Health, Inc.
Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Director/Miembro de la Junta | - |
Formación de Christoph Sven Hoffmann.
University of Basel | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Eastpharma Ltd.
Eastpharma Ltd. Pharmaceuticals: MajorHealth Technology Eastpharma Ltd. is a holding company, which engages in the production of pharmaceutical products. It operates through the following segments: Production and Sale of Human Pharmaceuticals, Veterinary Products, and Other. The Human Pharmaceuticals segment sells branded generic and licensed products; and manufactures and offers antibiotic active ingredients and empty ampoules. The Veterinary Products segment provides veterinary drugs and agrochemicals. The Other segment produces and sells cologne. The company was founded on August 17, 2006 and is headquartered in Hamilton, Bermuda. | Health Technology |
Sallfort Privatbank AG
Sallfort Privatbank AG Regional BanksFinance Sallfort Privatbank AG provides commercial banking, investment advisory, and asset management services. It also specializes in private equity, corporate finance, e-banking, and art consulting. The company was founded in 1981 and is headquartered in Zurich, Switzerland. | Finance |
Molecular Health, Inc.
Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Technology Services |
Roche Hong Kong Ltd. | |
Esocap AG
Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | Health Technology |
- Bolsa de valores
- Insiders
- Christoph Sven Hoffmann